Literature DB >> 10636916

The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.

M P de Caestecker1, T Yahata, D Wang, W T Parks, S Huang, C S Hill, T Shioda, A B Roberts, R J Lechleider.   

Abstract

Transforming growth factor-beta (TGF-beta) family members signal through a unique set of intracellular proteins called Smads. Smad4, previously identified as the tumor suppressor DPC4, is functionally distinct among the Smad family, and is required for the assembly and transcriptional activation of diverse, Smad-DNA complexes. We previously identified a 48-amino acid proline-rich regulatory element within the middle linker domain of this molecule, the Smad4 activation domain (SAD), which is essential for mediating these signaling activities. We now characterize the functional activity of the SAD. Mutants lacking the SAD are still able to form complexes with other Smad family members and associated transcription factors, but cannot activate transcription in these complexes. Furthermore, the SAD itself is able to activate transcription in heterologous reporter assays, identifying it as a proline-rich transcriptional activation domain, and indicating that the SAD is both necessary and sufficient to activate Smad-dependent transcriptional responses. We show that transcriptional activation by the SAD is p300-dependent, and demonstrate that this activity is associated with a physical interaction of the SAD with the amino terminus of p300. These data identify a novel function of the middle linker region of Smad4, and define the role of the SAD as an important locus determining the transcriptional activation of the Smad complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636916     DOI: 10.1074/jbc.275.3.2115

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

3.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells.

Authors:  Jay L Vivian; Yijing Chen; Della Yee; Elizabeth Schneider; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

5.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

6.  The Smad3 linker region contains a transcriptional activation domain.

Authors:  Guannan Wang; Jianyin Long; Isao Matsuura; Dongming He; Fang Liu
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

7.  Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription.

Authors:  Sarah Ross; Edwin Cheung; Thodoris G Petrakis; Michael Howell; W Lee Kraus; Caroline S Hill
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

Review 8.  Chromatin "pre-pattern" and epigenetic modulation in the cell fate choice of liver over pancreas in the endoderm.

Authors:  Cheng-Ran Xu; Kenneth S Zaret
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

9.  Inhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4.

Authors:  Shizu Hirata-Tsuchiya; Hidefumi Fukushima; Takenobu Katagiri; Satoshi Ohte; Masashi Shin; Kenichi Nagano; Kazuhiro Aoki; Takahiko Morotomi; Goro Sugiyama; Chihiro Nakatomi; Shoichiro Kokabu; Takahiro Doi; Hiroshi Takeuchi; Keiichi Ohya; Masamichi Terashita; Masato Hirata; Chiaki Kitamura; Eijiro Jimi
Journal:  Mol Endocrinol       Date:  2014-07-16

Review 10.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.